Literature DB >> 12082991

The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance.

J T Roehrig1, M Layton, P Smith, G L Campbell, R Nasci, R S Lanciotti.   

Abstract

In late summer 1999, the first domestically acquired human cases of WN encephalitis were documented in the USA. Aggressive vector-control and public education efforts by state and local public health officials limited the extent of human involvement. The discovery of virus-infected, overwintering mosquitoes during the winter of 1999-2000, predicted renewed virus activity for the following spring, and prompted early season vector-control activities and disease surveillance efforts in NYC and the surrounding areas. These surveillance efforts were focused on identifying WN virus infections in birds and mosquitoes as predictors of the potential risk of transmission to humans. By the end of the 2000 mosquito-borne disease transmission season, WN virus activity had been documented as far north as the states of Vermont and New Hampshire, and as far south as the state of North Carolina. The ongoing impacts that WN virus will have on wildlife, domestic animal and human populations of the western hemisphere are not yet known. Plans are in place for public health officials and scientists to monitor the further expansion of WN virus with the establishment or enhancement of vector-borne disease surveillance and control programs throughout the eastern seaboard. The valuable lessons learned from the detection and response to the introduction of WN virus into NYC should prove useful if and when subsequent intrusions of new disease agents occur.

Entities:  

Mesh:

Year:  2002        PMID: 12082991     DOI: 10.1007/978-3-642-59403-8_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  38 in total

1.  Detection of West Nile virus antigen in mosquitoes and avian tissues by a monoclonal antibody-based capture enzyme immunoassay.

Authors:  Ann R Hunt; Roy A Hall; Amy J Kerst; Roger S Nasci; Harry M Savage; Nicholas A Panella; Kristy L Gottfried; Kristen L Burkhalter; John T Roehrig
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus.

Authors:  Roy A Hall; Debra J Nisbet; Kim B Pham; Alyssa T Pyke; Greg A Smith; Alexander A Khromykh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-13       Impact factor: 11.205

3.  Development of human-murine chimeric immunoglobulin G for use in the serological detection of human flavivirus and alphavirus antibodies.

Authors:  Brett A Thibodeaux; Amanda N Panella; John T Roehrig
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

4.  Comparison of mosquito trapping method efficacy for West Nile virus surveillance in New Mexico.

Authors:  Mark A DiMenna; Rudy Bueno; Robert R Parmenter; Douglas E Norris; Jeff M Sheyka; Josephine L Molina; Elisa M LaBeau; Elizabeth S Hatton; Gregory E Glass
Journal:  J Am Mosq Control Assoc       Date:  2006-06       Impact factor: 0.917

5.  Why the West in West Nile virus infections?

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-09       Impact factor: 2.471

Review 6.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

7.  Development of a human-murine chimeric immunoglobulin M antibody for use in the serological detection of human flavivirus antibodies.

Authors:  Brett A Thibodeaux; John T Roehrig
Journal:  Clin Vaccine Immunol       Date:  2009-03-18

8.  Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses.

Authors:  Eva Lee; Roy A Hall; Mario Lobigs
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  West Nile virus surveillance and diagnostics: A Canadian perspective.

Authors:  Michael A Drebot; Robbin Lindsay; Ian K Barker; Peter A Buck; Margaret Fearon; Fiona Hunter; Paul Sockett; Harvey Artsob
Journal:  Can J Infect Dis       Date:  2003-03

10.  Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine.

Authors:  Asato Kojima; Atsushi Yasuda; Hideki Asanuma; Toyokazu Ishikawa; Akihisa Takamizawa; Kotaro Yasui; Takeshi Kurata
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.